Its British parent company GSK, which has been in Nigeria since 1971, said in 2018 that it would cut back its operations in Africa and adopt a distributor-led model instead of marketing medicines in 29 sub-Saharan African markets.
https://www.pharmalive.com/wp-content/uploads/2022/11/ReutersGSKlogo11-11-2022.webp8071200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-08-03 11:35:072023-08-04 10:12:14GSK Nigeria calls an end to its business, to return cash
